Role of NO on the cochlear blood flow regulation
Role of NO on the cochlear blood flow regulation
批准号:
12671688
负责人:
HAGINOMORI Shin-ichi
金额:
$0.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Endothelial nitric oxide synthase (eNOS) is known to be present in the endothelial cells of various blood vessels of the body, and produces nitric oxide (NO) which acts as on the vascular smooth muscle to dilate the vessels under physiologic conditions. Thus it plays an important role in the maintenance of vascular tone throughout the vascular tree. Previous studies have demonstrated histochemically and Immunohisto-chemically the presence of eNOS and its second messenger system (soluble guanylyl cyclase and cyclic GMP) in several areas of guinea pig and rat cochlea. We conducted an experiment using rats to observe the changes in cochlear blood flow (CoBF) after the administration of N-nitro-L-arginjne-methyl ester, L-NAME, an inhibitor of NOS employing a laser-Doppler flowmeter. Intravenous infusion or round window application of L-NAME produced a dose-dependent depression of CoBF. Infusion of L-arginine,which is a substrate of NO partially reversed the CoBF decrease caused by L-NAME. … More Such change in blood might have occurred in the blood flow of abdominal wall (AbBF) and auricular blood flow (AuBF), But the changes of AbBF and AuBF after intravenous infusion of L-NAME were less than the change of CoBF. NO could be involved in the reguiation of cochlear blood circulation in at least two sites ; capillaries of spiral ligament and spirai prominence, and the spirai modiolar artery. Since the vascular tone of spiral modiolar artery is one of the crucial factors in regulating cochlear blood flow and tissue oxygenation, control of the diameter at some portion of the spiral modiolar artery is thought to be an energetically effective means for blood flow regulation of downstream capililaries, There may exist the NO/soluble guanylate cyclase/cyclic GMP system thus functioning as a resistance vessel. Considering the results, these activities of the system in the cochleal vasculature may be higher compared with those in cutaneous vasculatures of the abdominal wall and auricle. From the findings of that study, they proposed that NOS is present in the cochlear vasculature, where NO is produced to play a pivotal role in the regulation of vascular tone. Less
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hoshijima H, Makimoto M, et al.: "Effect of nitric oxide synthase inhibitor on cochlear blood flow"Hear Res. 171. 32-42 (2002)
Hoshijima H、Makimoto M 等人:“一氧化氮合酶抑制剂对耳蜗血流的影响”Hear Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hideaki Hoshijima, Kazuo Makimoto, Osamu Noi, Yoshimitsu Ohinata, Hiroshi Takenaka: "Effects of nitric oxide synthase inhibitor on cochlear blood flow"Hearing Research. 171. 32-42 (2002)
Hideaki Hoshijima、Kazuo Makimoto、Osamu Noi、Yoshimitsu Ohinata、Hiroshi Takenaka:“一氧化氮合酶抑制剂对耳蜗血流的影响”听力研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
星島秀昭: "NO合成阻害剤局所投与によるラット蝸牛血流の変化"Otology Japan. 10・4. 535-535 (2000)
Hideaki Hoshijima:“NO合成抑制剂局部给药引起的大鼠耳蜗血流的变化”Otology Japan 10・4(2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shin-Ichi Haginomori: "Spontaneous otoacoustic emissions in humans with endolymphatic hydrops"Laryngoscope. 111・1. 96-101 (2001)
Shin-Ichi Haginomori:“患有内淋巴积水的人的自发性耳声发射”Laryngoscopy 111・1(2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hoshijima J, Makimoto M: "Decrease in cochlear blood flow with infusion of nitric oxide synthase inhibitor and its recovery with L-arginine infusion : comparison with abdominal blood flow and auricular blood flow"Acta Otolaryngol(Stockh). 122. 808-815 (20
Hoshijima J,Makimoto M:“输注一氧化氮合酶抑制剂导致的耳蜗血流量减少及其通过输注 L-精氨酸的恢复:与腹部血流量和耳廓血流量的比较”Acta Otolaryngol(Stockh)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
国内基金
海外基金
L-NAME通过抑制肾脏炎症治疗肾脏损伤的临床前研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘小亮
-
依托单位:
基于TRPV1与PBPK/PD探讨吴茱萸次碱超饱和透皮贴剂贴敷L-NAME诱导高血压大鼠神阙穴降血压的药穴结合效应研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:王森
-
依托单位: